相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets
Philippe de Medina et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators
Diego Gomez-Coronado et al.
SEMINARS IN CANCER BIOLOGY (2021)
Aging in COVID-19: Vulnerability, immunity and intervention
Yiyin Chen et al.
AGEING RESEARCH REVIEWS (2021)
Regulation of aromatase in cancer
Deborah Molehin et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Nuclear Dishevelled targets gene regulatory regions and promotes tumor growth
Isabel Castro-Piedras et al.
EMBO REPORTS (2021)
Mechanisms of endocrine therapy resistance in breast cancer
Fahmida Rasha et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
Endocrine prevention of breast cancer
Nusrat Jahan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
Regulation of aromatase expression: Potential therapeutic insight into breast cancer treatment
Deborah Molehin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
Relative Risk of Peripheral Neuropathy With Ado-Trastuzumab Emtansine (T-DM1) Compared to Taxane-Based Regimens in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Cancers: A Systematic Review and Meta-Analysis
Nusrat Jahan et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells
Philipp Y. Maximov et al.
MOLECULAR PHARMACOLOGY (2020)
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Flavia Alves Verza et al.
CANCERS (2020)
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
Balkees Abderrahman et al.
MOLECULAR PHARMACOLOGY (2020)
Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages
Elham Amjad et al.
SCIENTIFIC REPORTS (2020)
Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer
Bing Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition
Pulak R. Manna et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Early and late endothelial response in breast cancer metastasis in mice: simultaneous quantification of endothelial biomarkers using a mass spectrometry-based method
Joanna Suraj et al.
DISEASE MODELS & MECHANISMS (2019)
Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective
Pulak R. Manna et al.
CANCERS (2019)
Acetylation of conserved DVL-1 lysines regulates its nuclear translocation and binding to gene promoters in triple-negative breast cancer
Monica Sharma et al.
SCIENTIFIC REPORTS (2019)
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
Eylem Kulkoyluoglu-Cotul et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Rainer Girgert et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3 beta,5 alpha-diol (OCDO), a tumor promoter and cholesterol metabolite
Marc Poirot et al.
BIOCHIMIE (2018)
Deciphering the relative contribution of vascular inflammation and blood rheology in metastatic spreading
Hilaria Mollica et al.
BIOMICROFLUIDICS (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition
Deborah Molehin et al.
MOLECULAR CANCER RESEARCH (2018)
The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment
Hanjiao Qin et al.
PEERJ (2018)
DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells
Isabel Castro-Piedras et al.
Oncotarget (2018)
Steroid Hormones and Their Action in Women's Brains: The Importance of Hormonal Balance
Juan Pablo Del Rio et al.
FRONTIERS IN PUBLIC HEALTH (2018)
Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor
Maud Voisin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells
Amy E. Baek et al.
NATURE COMMUNICATIONS (2017)
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
Euphemia Y. Leung et al.
FRONTIERS IN ONCOLOGY (2017)
Targeting protein quality control pathways in breast cancer
Sara Sannino et al.
BMC BIOLOGY (2017)
Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death
Julie Leignadier et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Multifunctional Mitochondrial AAA Proteases
Steven E. Glynn
FRONTIERS IN MOLECULAR BIOSCIENCES (2017)
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells
Damiano Cosimo Rigiracciolo et al.
ONCOTARGET (2016)
Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: Who to treat more and who to treat less
Angela Toss et al.
BREAST (2016)
Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer
K. Harano et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
A single-center, open-label phase 1b study of entinostat, and lapatinib alone, and in combination with and trastuzumab in patients with HER2+metastatic breast cancer after progression on trastuzumab
B. Lim et al.
CANCER RESEARCH (2016)
Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer
Hirofumi Mukai et al.
CANCER SCIENCE (2016)
Efficacy and safety of trastuzumab combined with chemotherapy for first-line treatment and beyond progression of HER2-overexpressing advanced breast cancer
Huiping Li et al.
CHINESE JOURNAL OF CANCER RESEARCH (2016)
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients
Winston W. Tan et al.
CLINICAL BREAST CANCER (2016)
Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer
Si-Ying Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Aromatase expression and regulation in breast and endometrial cancer
Hong Zhao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells
Hei Jason Chan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
Anas Younes et al.
LANCET ONCOLOGY (2016)
Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer
Stephanie Legare et al.
MOLECULAR ENDOCRINOLOGY (2016)
Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics
Stephanie Kaypee et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Immunologic approaches to cancer prevention-current status, challenges, and future perspectives
Malgorzata E. Wojtowicz et al.
SEMINARS IN ONCOLOGY (2016)
Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer
Giuseppina Rosaria Rita Ricciardi et al.
ONCOTARGETS AND THERAPY (2016)
Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer
Tejal Joshi et al.
ONCOTARGET (2016)
Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells
Yumei Diao et al.
ONCOTARGET (2016)
An anti-ErbB2 fully human antibody circumvents trastuzumab resistance
Qiong Lu et al.
ONCOTARGET (2016)
Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ
Ameet K. Mishra et al.
ONCOTARGET (2016)
The interplay of epigenetic therapy and immunity in locally recurrent or metastatic estrogen receptor-positive breast cancer: Correlative analysis of ENCORE 301, a randomized, placebo-controlled phase II trial of exemestane with or without entinostat
Yusuke Tomita et al.
ONCOIMMUNOLOGY (2016)
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer
Nikiana Simigdala et al.
BREAST CANCER RESEARCH (2016)
Role of the steroidogenic acute regulatory protein in health and disease
Pulak R. Manna et al.
ENDOCRINE (2016)
Elevated Levels of StAR-Related Lipid Transfer Protein 3 Alter Cholesterol Balance and Adhesiveness of Breast Cancer Cells Potential Mechanisms Contributing to Progression of HER2-Positive Breast Cancers
Boris Vassilev et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer
R. T. Chlebowski et al.
CLIMACTERIC (2015)
Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation
Toshiki Mawatari et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
Steven J. Isakoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Celebrating 75 years of oestradiol
Evan Simpson et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Up-regulation of steroid biosynthesis by retinoid signaling: Implications for aging
Pulak R. Manna et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2015)
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy
Ping Fan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells
Amanda Schech et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
Maggie C. U. Cheang et al.
ONCOLOGIST (2015)
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
N. C. Hait et al.
ONCOGENESIS (2015)
Changing Treatment Paradigms in Metastatic Breast Cancer Lessons Learned
Cesar A. Santa-Maria et al.
JAMA ONCOLOGY (2015)
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen- resistant breast cancer models, by reversing Bcl-2 overexpression
Paromita Raha et al.
BREAST CANCER RESEARCH (2015)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer
Yifan Tu et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Upregulation of Steroidogenic Acute Regulatory Protein by Hypoxia Stimulates Aldosterone Synthesis in Pulmonary Artery Endothelial Cells to Promote Pulmonary Vascular Fibrosis
Bradley A. Maron et al.
CIRCULATION (2014)
The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol
Wan-Ru Lee et al.
CLINICAL LIPIDOLOGY (2014)
Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells
Taryn L. Green et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
StAR Enhances Transcription of Genes Encoding the Mitochondrial Proteases Involved in Its Own Degradation
Assaf Bahat et al.
MOLECULAR ENDOCRINOLOGY (2014)
On Estrogen, Cholesterol Metabolism, and Breast Cancer
Margaret Warner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway
Jiangxia Cai et al.
PHYTOMEDICINE (2014)
Cholesterol and Cancer, in the Balance
Sandrine Silvente-Poirot et al.
SCIENCE (2014)
Impact of radiation therapy on survival in patients with triple-negative breast cancer
Lauren T. Steward et al.
ONCOLOGY LETTERS (2014)
Estrogen signaling and the DNA damage response in hormone dependent breast cancers
C. Elizabeth Caldoe
FRONTIERS IN ONCOLOGY (2014)
Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development
Bramanandam Manavathi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2014)
Estrogen receptor signaling as a target for novel breast cancer therapeutics
Jack-Michel Renoir et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
Makoto Kubo et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Molecular Pathways: Extracting Medical Knowledge from High-Throughput Genomic Data
Theodore C. Goldstein et al.
CLINICAL CANCER RESEARCH (2013)
Mechanisms of Action of Hormone-sensitive Lipase in Mouse Leydig Cells ITS ROLE IN THE REGULATION OF THE STEROIDOGENIC ACUTE REGULATORY PROTEIN
Pulak R. Manna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
Denise A. Yardley et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Steroid hormone synthesis in mitochondria
Walter L. Miller
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
SIRT1 Positively Regulates Breast Cancer Associated Human Aromatase (CYP19A1) Expression
Kimberly R. Holloway et al.
MOLECULAR ENDOCRINOLOGY (2013)
Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo
Hui-Wen Chiu et al.
PLOS ONE (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis
Wei Yue et al.
STEROIDS (2013)
Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1
Masoumeh Tavakoli-Yaraki et al.
TUMOR BIOLOGY (2013)
Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species
C-W Cheng et al.
CELL DEATH & DISEASE (2013)
The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
Matthew J. Ellis et al.
CANCER DISCOVERY (2013)
27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
Qian Wu et al.
CELL REPORTS (2013)
Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations
Marco Boscaro et al.
BRAIN AND OBESITY (2012)
Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells
Xinfeng Yu et al.
BMC CANCER (2012)
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo
B. Ramaswamy et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter
V. Bartella et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Elizabeth A. Mittendorf et al.
CANCER (2012)
The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
Mieke Kriege et al.
CANCER (2012)
Intricacies of hedgehog signaling pathways: A perspective in tumorigenesis
Swayamsiddha Kar et al.
EXPERIMENTAL CELL RESEARCH (2012)
Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up
Lerner-Geva Liat et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Aromatase, breast cancer and obesity: a complex interaction
Serdar E. Bulun et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
G. M. A. Ajabnoor et al.
CELL DEATH & DISEASE (2012)
Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer
Tomasz Byrski et al.
BREAST CANCER RESEARCH (2012)
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
Chandra R. Tate et al.
BREAST CANCER RESEARCH (2012)
Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation
Oli M. V. Grober et al.
BMC GENOMICS (2011)
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
P. N. Munster et al.
BRITISH JOURNAL OF CANCER (2011)
A Phase 2 Study Investigating the Safety, Efficacy and Surrogate Biomarkers of Response of 5-Azacitidine (5-AZA) and Entinostat (MS-275) in Patients with Advanced Breast Cancer.
R. M. Connolly et al.
CANCER RESEARCH (2011)
Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells
Edita Aksamitiene et al.
CELLULAR SIGNALLING (2011)
Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation
Per E. Lonning et al.
CLINICAL CANCER RESEARCH (2011)
The Role of Hormonal Therapy in Gynecological Cancers-Current Status and Future Directions
Katrin M. Sjoquist et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
Todd W. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Early steps in steroidogenesis: intracellular cholesterol trafficking
Walter L. Miller et al.
JOURNAL OF LIPID RESEARCH (2011)
Autoregulation of cholesterol synthesis: Physiologic and pathophysiologic consequences
Robert J. Fakheri et al.
STEROIDS (2011)
Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
Salome Gonzalez-Reyes et al.
BMC CANCER (2010)
Hormonal and metabolic modulation through nutrition: Towards a primary prevention of breast cancer
Alvaro L. Ronco et al.
BREAST (2010)
Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
Kathryn N. Phoenix et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A Phase II Study of the Histone Deacetylase Inhibitor, Vorinostat, in Combination with Trastuzumab in Patients with Advanced Metastatic and/or Local Chest Wall Recurrent HER-2 Amplified Breast Cancer Resistant to Transtuzumab-Containing Therapy: (E1104) a Trial of the Eastern Cooperative Oncology Group.
R. Swaby et al.
CANCER RESEARCH (2010)
The Safety and Tolerability of Panobinostat (LBH589) in Combination with Capecitabine plus /- Lapatinib: A Phase I Study in HER2+Breast Cancer
N. W. Peacock et al.
CANCER RESEARCH (2010)
Molecularly targeted endocrine therapies for breast cancer
L. Orlando et al.
CANCER TREATMENT REVIEWS (2010)
Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy
Giorgia Urbinati et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Tumor Necrosis Factor, Lymphotoxin and Cancer
Marina S. Drutskaya et al.
IUBMB LIFE (2010)
A multi-institutional double-blind phase II study evaluationg response and surrogate biomarkers to carboplatin and nab-paclitaxel (CP) with or without vorinostat as preperative systemic therapy (PST) in HER2-negative primary operable breast cancer (TBCRC008).
R. M. Connolly et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor-Positive Breast Cancer in Postmenopausal Women
Anita K. Dunbier et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy
Stuart J. Schnitt
MODERN PATHOLOGY (2010)
Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice
Nripen Chanda et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Lasofoxifene in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression
Shiuan Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hormone Action in the Mammary Gland
Cathrin Brisken et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Trichostatin A enhances acetylation as well as protein stability of ER alpha through induction of p300 protein
Sung-Hye Kim et al.
BREAST CANCER RESEARCH (2010)
Autocrine/paracrine regulations of steroidogenesis in adrenocortical hyperplasias and tumors
H. Lefebvre et al.
ANNALES D ENDOCRINOLOGIE (2009)
Regulation of Aromatase Expression in Breast Cancer Tissue
S. E. Bulun et al.
STEROID ENZYMES AND CANCER (2009)
Molecular Characterization of Aromatase
Yanyan Hong et al.
STEROID ENZYMES AND CANCER (2009)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells
Qun Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
Somaia E. Elsheikh et al.
CANCER RESEARCH (2009)
Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
Diane Palmieri et al.
CLINICAL CANCER RESEARCH (2009)
Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts
Andrew Baschnagel et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives
Pulak R. Manna et al.
MOLECULAR HUMAN REPRODUCTION (2009)
Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: Role in health and disease and their therapeutic potential
Amazia Zimber et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Liver X Receptor Activation Induces the Uptake of Cholesteryl Esters From High Density Lipoproteins in Primary Human Macrophages
Stephanie Bultel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Taxanes, microtubules and chemoresistant breast cancer
Barbara T. McGrogan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2008)
Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells
Nicoletta Fortunati et al.
CANCER LETTERS (2008)
Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma
Joan Montero et al.
CANCER RESEARCH (2008)
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells
Qun Zhou et al.
MOLECULAR CANCER RESEARCH (2008)
Estrogen and Its Receptors in Cancer
George G. Chen et al.
MEDICINAL RESEARCH REVIEWS (2008)
MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways
Boris J. Cheskis et al.
STEROIDS (2008)
Selective estrogen-receptor modulators and antihormonal resistance in breast cancer
V. Craig Jordan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation
David M. Lonard et al.
MOLECULAR CELL (2007)
Targeting lymphotoxin β receptor with tumor-specific T lymphocytes for tumor regression
Dafeng Yang et al.
CLINICAL CANCER RESEARCH (2007)
Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells
Arthur Edwards et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Aromatase excess in cancers of breast, endometrium and ovary
Serdar E. Bulun et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Risk of breast cancer after exposure to fertility drugs: Results from a large Danish cohort study
Allan Jensen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Turnover of StAR protein: Roles for the proteasome and mitochondrial proteases
Zvi Granot et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Estrogen receptor modulators and down regulators - Optimal use in postmenopausal women with breast cancer
Christa K. Baumann et al.
DRUGS (2007)
Genome-wide analysis of estrogen receptor binding sites
Jason S. Carroll et al.
NATURE GENETICS (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Mechanisms of disease: Estrogen carcinogenesis in breast cancer
JD Yager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mitochondrial cholesterol transport: A possible target in the management of hyperlipidemia
EA Hall et al.
LIPIDS (2005)
Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: More complicated than we thought
DM Stocco et al.
MOLECULAR ENDOCRINOLOGY (2005)
The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment
MFM Mitwally et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma
QC Ryan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Regulation of aromatase expression in estrogen-responsive breast and uterine disease: From bench to treatment
SE Bulun et al.
PHARMACOLOGICAL REVIEWS (2005)
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
CK Osborne et al.
BRITISH JOURNAL OF CANCER (2004)
Plasma deoxycholic acid concentration is elevated in postmenopausal women with newly diagnosed breast cancer
V Costarelli et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2002)
分享论文
